ArdorComm Media Group

healthcare

From Panic to Precision: Revolutionizing Code Blue Responses in Healthcare

The frequent blare of a “Code Blue” alarm signals critical, life-threatening emergencies demanding swift and accurate responses. A meticulous 24-month analysis across tertiary care hospitals reveals a daunting reality – 720 Code Blue calls, with 620 genuine emergencies and a survival rate plummeting to 11.13% for cardiac arrests. This stark scenario necessitates a paradigm shift in the approach to emergency healthcare, inspiring a journey from panic to precision. India’s healthcare sector, once plagued by high mortality rates due to limited access to intensive care and delayed data delivery, is now at a crossroads of transformation. Innovative technologies, such as the Medical Internet of Things (IoT), Artificial Intelligence (AI), and Machine Learning (ML), are heralding a revolution in wireless patient monitoring, bridging the gap between conventional methods and cutting-edge solutions. To avert Code Blue events, a multifaceted approach is imperative, transcending reactive measures to embrace proactive strategies. Wireless patient monitoring, empowered by AI and ML, emerges as a cornerstone in this transformation. By continuously analyzing real-time vital signs, these devices act as alert sentinels, allowing healthcare providers to identify subtle changes and intervene before emergencies escalate. Predictive analytics and machine learning algorithms enhance the system’s ability to recognize patterns, contributing to a shift from crisis management to prevention. The traditional Code Blue model, while vital, comes with limitations, often triggering rushed and unorganized responses. Communication breakdowns, unfamiliarity with patients, and the high-stakes nature of the situation contribute to chaos, potentially compromising patient outcomes. To address these challenges, a shift from a reactive, panic-driven model to a proactive, precision-based approach is imperative, facilitated by continuous patient monitoring solutions. Wireless patient monitoring, akin to watchful conductors, plays a pivotal role in reducing Code Blue emergencies. These devices provide real-time vital sign data, enabling healthcare experts to respond swiftly in critical situations. In a study involving 3100 patients, real-time data transmission resulted in an 87% decrease in hospital stays, a 77% drop in deaths, and significant cost savings for patients, emphasizing the transformative impact of wireless patient monitoring on healthcare outcomes. The success of wireless patient monitoring marks not only a transformation from panic to precision but also heralds an overture of proactive care. Continuous monitoring of vital signs allows healthcare providers to anticipate and address potential issues before they escalate, reshaping emergency healthcare into a proactive, preventive paradigm. As India embraces the era of wireless patient monitoring, the ripple effects on the healthcare system are evident, transcending statistics to impact lives and improve the quality of care. The journey from panic to precision in Code Blue responses signifies a chain of transformation, rewriting the narrative of emergency healthcare and ensuring timely and effective interventions. The evolution from traditional patient monitoring to wireless solutions, complemented by cutting-edge technologies, is a beacon of hope for the healthcare industry. It represents a symphony of progress, reshaping and redefining healthcare to be more precise, proactive, and ultimately, more humane. The future has arrived, ushering in a new era where emergencies are met with the precision of a well-conducted symphony, thanks to the marriage of innovation and compassionate care.

WHO Calls for Regulation of AI in Healthcare Due to Risks, Citing Bias and Privacy Concerns

News on Health

The World Health Organization (WHO) is calling for the regulation of artificial intelligence (AI) in healthcare due to the associated risks, according to a report. WHO emphasizes the need to establish safety and efficacy in AI tools, make them accessible to those who require them, and encourage communication among AI developers and users. While recognizing AI’s potential to enhance healthcare by strengthening clinical trials, improving diagnosis and treatment, and enhancing healthcare professionals’ knowledge and skills, the report by data and analytics company GlobalData highlights the rapid deployment of AI technologies without a full understanding of their long-term implications, which could pose risks to healthcare professionals and patients. Alexandra Murdoch, a Senior Analyst at GlobalData, acknowledges the significant benefits of AI in healthcare but also highlights the risks associated with rapid adoption. AI systems in healthcare often have access to personal and medical information, necessitating regulatory frameworks to ensure privacy and security. Other challenges with AI in healthcare include unethical data collection, cybersecurity vulnerabilities, and the reinforcement of biases and dissemination of misinformation. An example of AI biases is found in a Stanford University study, which revealed that some AI chatbots provided inaccurate medical information about people of color. In this study, nine questions were posed to four AI chatbots, including OpenAI’s ChatGPT and Google’s Bard, and all four chatbots provided inaccurate information related to race and kidney and lung function. The use of such false medical information is a cause for concern, as it could lead to issues like misdiagnoses and improper treatment for patients of color. WHO has identified six areas for regulating AI in healthcare, with a focus on managing the risks associated with AI amplifying biases in training data. These areas for regulation include transparency and documentation, risk management, data validation and clarity of AI’s intended use, a commitment to data quality, privacy and data protection, and the promotion of collaboration. Alexandra Murdoch hopes that by outlining these regulatory areas, governments and regulatory bodies can develop regulations to safeguard healthcare professionals and patients while fully harnessing the potential of AI in healthcare.

India Leads Global Preterm Births in 2020, Lancet Study Reveals

In 2020, India witnessed the highest number of preterm births globally, with a staggering 3.02 million cases, constituting over 20 percent of all premature births worldwide, as revealed by a study published in The Lancet journal. This research, conducted by experts from the World Health Organization (WHO), the United Nations Children’s Fund (UNICEF), and the London School of Hygiene and Tropical Medicine, UK, further disclosed that more than half of all premature births in 2020 occurred in just eight countries. Following India, the countries with the highest preterm birth rates were Pakistan, Nigeria, China, Ethiopia, Bangladesh, the Democratic Republic of the Congo, and the United States, according to the researchers. The notable prevalence of preterm births in these regions is partly attributable to their substantial population sizes, high numbers of total births, and underdeveloped healthcare systems that struggle to provide high-quality family planning, antenatal care, and childbirth services to all those in need. Globally, approximately 13.4 million babies were born prematurely in 2020, with nearly one million succumbing to complications associated with preterm birth. This data equates to roughly one in ten babies being born prematurely, before completing 37 weeks of pregnancy worldwide. Given that prematurity ranks as the leading cause of child mortality in their early years, there is an urgent need to bolster both preterm infant care and preventative measures, particularly focusing on maternal health and nutrition to enhance child survival, emphasize the authors of the study. Furthermore, preterm birth significantly increases the likelihood of major illnesses, disabilities, developmental delays, and even chronic diseases like diabetes and heart conditions in adulthood for those who survive. This study derives its estimates from data that is representative of populations and national statistics, enabling internationally comparable assessments for the year 2020. It highlighted that India had the highest incidence of preterm births in 2020, totalling 3.02 million cases, accounting for over a fifth of all preterm births worldwide. While most high preterm birth rates were observed in low and middle-income nations, rates of 10 percent or higher were also evident in high-income countries such as Greece and the United States. Within South Asia, Bangladesh reported the highest preterm birth rate in 2020 at 16.2 percent, followed by Pakistan at 14.4 percent, and India at 13.0 percent. In Latin America, the rates ranged from 5.8 percent in Nicaragua to 12.8 percent in Suriname. As birth registration and facility-based deliveries have increased, data on the prevalence of preterm births has improved. Nevertheless, there are still 92 countries lacking sufficient nationally representative data. Consequently, the authors call for sustained efforts to enhance data availability, quality, and sharing to better target support and action where it is most needed. Dr. Anshu Banerjee, Director of Maternal, Newborn, Child, and Adolescent Health and Ageing at WHO, emphasized the vulnerability of preterm babies to life-threatening health complications and the necessity for dedicated care and attention. He stressed the urgency of substantial investments in services supporting preterm infants and their families, as well as a heightened focus on prevention, particularly ensuring access to quality healthcare before and during pregnancies. The researchers underscored that preterm birth is not exclusive to low and middle-income countries, as the data clearly reveals its impact on families worldwide, including some high-income countries such as Greece (11.6 percent) and the United States (10 percent).

U-Win Portal Revolutionizes Routine Immunization Records

The government is gearing up to introduce the ‘U-Win’ portal, modelled after the successful Co-Win COVID-19 vaccine management system. This new platform is aimed at maintaining a digital registry of routine immunizations as part of the Universal Immunization Programme (UIP). Currently, the U-Win initiative is undergoing a pilot phase in two districts of each state and Union Territory. The U-Win portal, similar to Co-Win, was initially launched on January 11 in 65 districts nationwide. At present, UIP vaccination records are managed manually, but U-Win will eliminate the need for physical records. It will facilitate the digitization of session planning and provide real-time updates on vaccination statuses. This will address challenges posed by multiple vaccines and doses, as well as the absence of an individual tracking mechanism. Furthermore, it aims to raise awareness among beneficiaries regarding session details, locations, and dates, especially in urban areas, while also addressing disparities in immunization coverage among states and Union Territories. A significant issue to tackle is the lack of record-keeping for immunizations administered at private health facilities. U-Win seeks to become the centralized repository for immunization service information, encompassing pregnancy details, newborn registrations, and vaccinations at birth. The system will also maintain live updates on vaccination statuses, delivery outcomes, and the planning of routine immunization sessions. It aims to provide personalized tracking for pregnant women and newborns, sending reminders for upcoming doses and following up on dropouts. The U-Win platform will empower healthcare workers and program managers with real-time data on routine immunization sessions and vaccine coverage, facilitating better planning and distribution. Additionally, it will offer information on upcoming sessions in specific areas for the following month and a list of beneficiaries due for vaccination. Pregnant women and children will receive vaccine acknowledgments and immunization cards linked to their Ayushman Bharat Health Account (ABHA ID). States and districts will have access to a common database for efficient tracking and vaccination of beneficiaries. Citizens can also check nearby routine immunization sessions and book appointments through the platform. Lastly, all electronic vaccination certificates, similar to COVID vaccination certificates, will include pictures of Prime Minister Narendra Modi. As of August 28, U-Win has registered over 6.8 million beneficiaries and digitally tracked more than 13 million vaccine doses. This includes registrations for 33,58,770 infants aged 0-1 years, 20,98,338 children aged 1-5 years, and 14,20,708 pregnant women, with 1,32,60,903 doses being tracked digitally.

PM Modi Highlights India’s Inclusive Tech Initiatives and Global Impact

In an interview with a news agency, Prime Minister Modi discussed how India’s digital public infrastructure is promoting social inclusion and democratizing technology. He emphasized that India’s efforts have gained global recognition and are paving the way for a broader global movement. Prime Minister Modi highlighted the success of the CoWIN initiative, which facilitated the world’s largest vaccine drive, providing over 200 crore free doses. The platform, CoWIN, was even made open source for other countries to adopt. Referring to the UPI initiative, Modi noted that digital transactions are empowering businesses of all sizes, from street vendors to major banks, and contributing to financial inclusion. He praised India’s Digital Public Infrastructure for its role in delivering public services during the pandemic, citing the Jan Dhan-Aadhar-Mobile (JAM) Trinity’s effectiveness in ensuring financial inclusion and benefit transfers. Modi also mentioned the ONDC e-commerce initiative, which is seen as a significant step in democratizing digital platforms and creating a level playing field. He discussed the adoption of India’s digital public infrastructure by the G20 forum, which has established principles for a secure digital economy and laid the foundation for the One Future Alliance to coordinate global efforts in this regard. Prime Minister Modi highlighted the Ayushman Bharat Digital Mission’s impact on healthcare service delivery and India’s commitment to global health through the G20’s Global Digital Health Initiative. He stressed India’s approach of using technology to promote inclusion and equality, turning it into a force for good. Modi also addressed the government’s efforts to enhance cybersecurity, acknowledging the challenges posed by technology in combating illicit financial activities and terrorism. The Prime Minister celebrated India’s achievements across various domains, including the space sector, startups, sports, and education, expressing optimism about India’s economic prospects in the near future. This interview provides valuable insights into India’s efforts to leverage technology for social inclusion and global cooperation. Interview link: https://www.pmindia.gov.in/en/news_updates/ptis-exclusive-interview-with-prime-minister-narendra-modi/

Aurobindo Pharma Gets USFDA Approval for Icatibant Injection

 A significant achievement for Aurobindo Pharma emerges as its wholly-owned subsidiary, Eugia Pharma Specialities, gains the final green light from the US health authority for the production and distribution of a generic Icatibant injection. This injection is integral in addressing hereditary angioedema. The endorsement, bestowed by the US Food & Drug Administration (USFDA), pertains to the 30 mg/3 mL (10 mg/mL) strength of Icatibant injection, presented as a single-dose pre-filled syringe. Aurobindo Pharma disclosed this development through an official filing. Distinguished as both bioequivalent and therapeutically tantamount to Takeda Pharmaceuticals USA Inc’s reference listed drug FIRAZYR (Icatibant injection), this milestone holds considerable significance. The company announced the scheduled launch of this product in September 2023. Drawing attention to its market potential, Aurobindo Pharma indicated that the approved offering corresponds to a market size valued at approximately USD 137 million, as per IQVIA data encompassing the 12 months concluding in June 2023.

Healthcare digital transformation is being slowed down by inflation and rising costs: GlobalData

According to a survey conducted by GlobalData, 58% of healthcare industry professionals worldwide think that initiatives involving the adoption of cutting-edge technologies like artificial intelligence (AI), big data, cloud computing, application programming interfaces (API), and others will be slowed down by inflation and rising costs. According to a survey that was included in GlobalData’s most recent report, “Digital Transformation and Emerging Technology in the Healthcare Industry – 2022 Edition,” 63% of North American professionals in the healthcare and pharmaceutical industries predicted that inflation would have an impact on their business units’ digitalization initiatives. 55% of industry professionals in Europe and 47% in the Asia-Pacific regions shared the same viewpoint. Rising labour and material costs have taken centre stage in 2022, according to Elton Kwok, Market Research Manager of Pharma at GlobalData. It is anticipated that inflation would put some pressure on the profit growth of the pharmaceutical industry, leading to a decline in investment activities that could have an influence on digital transformation initiatives. Inflation and cost concerns may force organisations to reduce their attention on and investment in these projects. Digitalization needs funds, time, and expertise. The power of technologies to promote cost reduction, however, led more than 20% of survey participants to conclude that inflation may in fact function as a stimulus for attempts to implement digital transformation. According to Kwok’s conclusion, even though emerging technologies entail a large investment in terms of time, labour, and money, some organisations continue to find them attractive.